Cargando…

Rate or Rhythm Control in CRT (RHYTHMIC): Study rationale and protocol

BACKGROUND: Atrial fibrillation (AF) has several detrimental effects on heart failure patients treated with cardiac resynchronization therapy (CRT). These include suboptimal biventricular pacing and the loss of atrioventricular (AV) synchrony. AV node ablation improves biventricular pacing and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliott, Mark K., de Vere, Felicity, Mehta, Vishal S., Wijesuriya, Nadeev, Strocchi, Marina, Rajani, Ronak, Niederer, Steven, Rinaldi, Christopher A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Design Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795294/ https://www.ncbi.nlm.nih.gov/pubmed/36589918 http://dx.doi.org/10.1016/j.hroo.2022.09.001

Ejemplares similares

The role of conduction system pacing in patients with atrial fibrillation
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Pacing interventions in non-responders to cardiac resynchronization therapy
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Managing arrhythmia in cardiac resynchronisation therapy
por: de Vere, Felicity, et al.
Publicado: (2023)

Leadless Pacing: Therapy, Challenges and Novelties
por: Wijesuriya, Nadeev, et al.
Publicado: (2023)

Leadless Left Bundle Branch Area Pacing in Cardiac Resynchronisation Therapy: Advances, Challenges and Future Directions
por: Wijesuriya, Nadeev, et al.
Publicado: (2022)

Long-term survival following transvenous lead extraction: unpicking differences according to sex
por: Mehta, Vishal S, et al.
Publicado: (2023)

Comparison between conduction system pacing and cardiac resynchronization therapy in right bundle branch block patients
por: Strocchi, Marina, et al.
Publicado: (2022)

Leadless biventricular left bundle and endocardial lateral wall pacing versus left bundle only pacing in left bundle branch block patients
por: Strocchi, Marina, et al.
Publicado: (2022)

Rationale and design for ENHANCE CRT: QLV implant strategy for non‐left bundle branch block patients
por: Singh, Jagmeet P., et al.
Publicado: (2018)

Rationale and design of the IRON‐CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
por: Martens, Pieter, et al.
Publicado: (2019)

Multi-lead pacing for cardiac resynchronization therapy in heart failure: a meta-analysis of randomized controlled trials
por: Elliott, Mark K, et al.
Publicado: (2022)

Dispersion of repolarization increases with cardiac resynchronization therapy and is associated with left ventricular reverse remodeling
por: Elliott, Mark K., et al.
Publicado: (2022)

Transvenous lead extraction in conduction system pacing
por: Wijesuriya, Nadeev, et al.
Publicado: (2022)

Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C
por: Reddy, K Rajender, et al.
Publicado: (2012)

Feasibility of intraprocedural integration of cardiac CT to guide left ventricular lead implantation for CRT upgrades
por: Gould, Justin, et al.
Publicado: (2021)

Rationale and design of the EMPYREAN study
por: Motoki, Hirohiko, et al.
Publicado: (2020)

Rationale and design of the AUGUST‐AHF Study
por: Zhang, Jingjing, et al.
Publicado: (2020)

Atrial fibrillation associated with heart failure treated by a 2-lead CRT-DX system (BIO-AffectDX): Study design and clinical protocol
por: Hsu, Jonathan C., et al.
Publicado: (2021)

Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: Rationale and design of the EARNEST study()
por: Moody, William E., et al.
Publicado: (2014)

Mechanisms of Diuretic Resistance Study: design and rationale
por: Cox, Zachary L., et al.
Publicado: (2020)

Rationale and design of a smartphone‐enabled, home‐based exercise program in patients with symptomatic peripheral arterial disease: The smart step randomized trial
por: Harzand, Arash, et al.
Publicado: (2020)

The genomics of heart failure: design and rationale of the HERMES consortium
por: Lumbers, R. Thomas, et al.
Publicado: (2021)

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
por: Bhatt, Deepak L., et al.
Publicado: (2019)

Rationale and Design of the PRegnancy and Infant DEvelopment (PRIDE) Study
por: van Gelder, Marleen M H J, et al.
Publicado: (2013)

Design and rationale of the North Indian ST‐Segment Elevation Myocardial Infarction Registry: A prospective cohort study
por: Arora, Sameer, et al.
Publicado: (2019)

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
por: Bhatt, Deepak L., et al.
Publicado: (2017)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

Kyoto Congestive Heart Failure (KCHF) study: rationale and design
por: Yamamoto, Erika, et al.
Publicado: (2017)

German Cardiac Arrest Registry: rationale and design of G-CAR
por: Pöss, Janine, et al.
Publicado: (2022)

The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network
por: Davies, Brianna, et al.
Publicado: (2020)

TranslatiOnal Registry for CardiomyopatHies (TORCH) – rationale and first results
por: Seyler, Claudia, et al.
Publicado: (2017)

Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy
por: Farrant, John, et al.
Publicado: (2023)

Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design
por: Lainscak, Mitja, et al.
Publicado: (2019)

Rationale and design of the CardioMEMS Post‐Market Multinational Clinical Study: COAST
por: Cowie, Martin R., et al.
Publicado: (2020)

Regional management of worsening heart failure: rationale and design of the CHAIN‐HF registry
por: Shakoor, Abdul, et al.
Publicado: (2023)

Sacubitril/valsartan for cardioprotection in breast cancer (MAINSTREAM): design and rationale of the randomized trial
por: Tajstra, Mateusz, et al.
Publicado: (2023)

Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017)

Rationale and design of the EPCHF trial: the early palliative care in heart failure trial (EPCHF)
por: Becher, Marc Ulrich, et al.
Publicado: (2021)

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
por: Dauw, Jeroen, et al.
Publicado: (2021)

Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE)
por: Paitazoglou, Christina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bf5uj1l2oljlqiahl50967t7gv